Vaxcyte Inc
NASDAQ:PCVX
During the last 3 months Vaxcyte Inc insiders have not bought any shares, and sold 1.6m USD worth of shares. The stock price has dropped by 64% over this period (open performance analysis).
The last transaction was made on
Mar 5, 2025
by
Eydelman Mikhail
(Chief Financial Officer)
, who
sold
184.5k USD
worth of PCVX shares.
During the last 3 months Vaxcyte Inc insiders have not bought any shares, and sold 1.6m USD worth of shares. The stock price has dropped by 64% over this period (open performance analysis).
The last transaction was made on
Mar 5, 2025
by
Eydelman Mikhail
(Chief Financial Officer)
, who
sold
184.5k USD
worth of PCVX shares.
Vaxcyte Inc
Glance View
Vaxcyte Inc. has carved a niche in the biotechnology industry with its focus on developing next-generation vaccines to tackle some of the most challenging infectious diseases. The company, headquartered in San Carlos, California, leverages its proprietary cell-free protein synthesis platform, XpressCF™, which enables the rapid production of complex proteins at scale. This technology forms the backbone of its vaccine development process, allowing Vaxcyte to bypass traditional cell-based methods that can be both time-consuming and costly. At the core of Vaxcyte's mission is its commitment to addressing unmet medical needs by enhancing the efficacy and safety profiles of vaccines, ultimately aiming to deliver superior alternatives to existing products on the market. Vaxcyte's business model is built on a strategic blend of research and development, partnerships, and intellectual property. The company invests heavily in R&D to advance its pipeline of vaccine candidates, with a particular emphasis on conjugate vaccines targeting bacterial infections such as pneumococcal diseases. Revenue generation is primarily driven through collaborations and licensing agreements with larger pharmaceutical companies that provide upfront payments, milestones, and potential royalties. These partnerships not only validate Vaxcyte’s scientific approach but also furnish the essential capital to sustain its innovative programs and bring its cutting-edge vaccines to market. As Vaxcyte continues to make strides in vaccine development, the company positions itself as a key player in the quest for more effective disease prevention solutions.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet